Infant-onset progressive myoclonus epilepsy

Area of Science:

• Pediatric Neurology
• Mitochondrial Medicine
• Epilepsy Syndromes

Background:

• Infant-onset progressive myoclonus epilepsy (IPME) presents with severe neurological impairment.
• Diagnosis can be challenging, requiring a multi-faceted approach.

Purpose of the Study:

• To characterize clinical, electroencephalographic, and neuroimaging findings in IPME.
• To investigate the role of muscle biopsy and respiratory chain enzyme studies in diagnosing IPME.
• To identify common underlying etiologies of IPME.

Main Methods:

• Clinical assessment, electroencephalography (EEG), neuroimaging, and muscle biopsy.
• Histopathological examination and respiratory chain enzyme activity assays on muscle tissue.
• Analysis of serum and cerebrospinal fluid lactate levels.

Main Results:

• Eight children with IPME exhibited myoclonic seizures, generalized tonic-clonic seizures, and neurological regression.
• EEG showed slow background activity with multifocal discharges; no burst suppression or photoparoxysmal response.
• Muscle biopsies revealed non-specific mitochondrial abnormalities in seven children; three had Complex I respiratory chain defects (low NADH cytochrome c reductase).
• Ragged-red fibers were absent in all samples, yet mitochondrial enzyme defects were present.

Conclusions:

• IPME can be distinguished from other infantile epilepsy syndromes by clinical and electrographic features.
• Respiratory chain enzyme defects are a significant cause of IPME.
• Absence of ragged-red fibers does not exclude mitochondrial enzyme abnormalities in IPME diagnosis.